| ABR-OPA1-15297-C050 | PAb to Cannabinoid Receptor 1 [CB1] (human) | 50 µg |
| ABR-OPA1-15298-C050 | PAb to Putative Neurotransmitter Receptor [PNR] (human) (cytoplasmic loop) | 50 µg |
| ABR-OPA1-15299-C050 | PAb to Metabotropic Glutamate Receptor 3 [mGluR3] (human) | 50 µg |
| ABR-OPA1-15300-C050 | PAb to Metabotropic Glutamate Receptor 3 [mGluR3] (human) | 50 µg |
| ABR-OPA1-15301-C050 | PAb to Olfactory Receptor OR6N1 (human) | 50 µg |
| ABR-OPA1-15302-C050 | PAb to Olfactory Receptor OR6N1 (human) | 50 µg |
| ABR-OPA1-15303-C050 | PAb to G Protein-Coupled Receptor GPR75 (human) | 50 µg |
| ABR-OPA1-15304-C050 | PAb to G Protein-Coupled Receptor GPR75 (human) | 50 µg |
| ABR-OPA1-15305-C050 | PAb to G Protein-Coupled Receptor GPR58 (human) | 50 µg |
| ABR-OPA1-15307-C050 | PAb to G Protein-Coupled Receptor GPR57 (human) | 50 µg |
| ABR-OPA1-15308-C050 | PAb to G Protein-Coupled Receptor GPR78 (human) | 50 µg |
| ABR-OPA1-15309-C050 | PAb to Prostaglandin D2 Receptor (human) (extracellular loop) | 50 µg |
| ABR-OPA1-15310-C050 | PAb to G Protein-Coupled Receptor GPR57 (human) | 50 µg |
| ABR-OPA1-15311-C050 | PAb to Neuropeptide FF2 Receptor (human) | 50 µg |
| ABR-OPA1-15312-C050 | PAb to Cysteinyl Leukotriene Receptor 2 (CysLT2) (human) | 50 µg |
| ABR-OPA1-15313-C050 | PAb to G Protein-Coupled Receptor RE2 (human) | 50 µg |
| ABR-OPA1-15314-C050 | PAb to Purinergic Receptor P2U2 (human) | 50 µg |
| ABR-OPA1-15315-C050 | PAb to 5-HT1F Receptor (human) | 50 µg |
| ABR-OPA1-15316-C050 | PAb to 5-HT1F Receptor (human) | 50 µg |
| ABR-OPA1-15317-C050 | PAb to 5-HT1F Receptor (human) | 50 µg |
| ABR-OPA1-15318-C050 | PAb to GPRv40 (human) | 50 µg |
| ABR-OPA1-15320-C050 | PAb to G Protein-Coupled Receptor GPR85 (human) | 50 µg |
| ABR-OPA1-15321-C050 | PAb to G Protein-Coupled Receptor EX33 (human) | 50 µg |
| ABR-OPA1-15322-C050 | PAb to G Protein-Coupled Receptor EX33 (human) | 50 µg |
| ABR-OPA1-15323-C050 | PAb to Vomeronasal 1 Receptor 1 [VN1R1] (human) | 50 µg |
| ABR-OPA1-15324-C050 | PAb to Vomeronasal 1 Receptor 1 [VN1R1] (human) | 50 µg |
| ABR-OPA1-15325-C050 | PAb to Vomeronasal 1 Receptor 1 [VN1R1] (human) | 50 µg |
| ABR-OPA1-15326-C050 | PAb to Vomeronasal 1 Receptor 1 [VN1R1] (human) | 50 µg |
| ABR-OPA1-15327-C050 | PAb to G Protein-Coupled Receptor GPR52 (human) | 50 µg |
| ABR-OPA1-15328-C050 | PAb to G Protein-Coupled Receptor GPR44 (human) | 50 µg |
| ABR-OPA1-15329-C050 | PAb to G Protein-Coupled Receptor GPR44 (human) | 50 µg |
| ABR-OPA1-15330-C050 | PAb to G Protein-Coupled Receptor GPR44 (human) | 50 µg |
| ABR-OPA1-15331-C050 | PAb to CCR6 (human) | 50 µg |
| ABR-OPA1-15332-C050 | PAb to Retinoic Acid-Induced 3 (human) | 50 µg |
| ABR-OPA1-15333-C050 | PAb to Retinoic Acid-Induced 3 (human) | 50 µg |
| ABR-OPA1-15334-C050 | PAb to CCR6 (human) | 50 µg |
| ABR-OPA1-15335-C050 | PAb to G Protein-Coupled Receptor GPR48 (human) | 50 µg |
| ABR-OPA1-15336-C050 | PAb to G Protein-Coupled Receptor GPR48 (human) | 50 µg |
| ABR-OPA1-15337-C050 | PAb to Corticotropin-Releasing Factor Receptor 2 [CRHR2] (human) | 50 µg |
| ABR-OPA1-15338-C050 | PAb to Corticotropin-Releasing Factor Receptor 2 [CRHR2] (human) | 50 µg |
| ABR-OPA1-15339-C050 | PAb to Bradykinin B1 Receptor (human) | 50 µg |
| ABR-OPA1-15341-C050 | PAb to G Protein-Coupled Receptor GPR48 (human) | 50 µg |
| ABR-OPA1-15342-C050 | PAb to G Protein-Coupled Receptor D6 | 50 µg |
| ABR-OPA1-15343-C050 | PAb to G Protein-Coupled Receptor D6 | 50 µg |
| ABR-OPA1-15345-C050 | PAb to G Protein-Coupled Receptor G2A (human) | 50 µg |
| ABR-OPA1-15347-C050 | PAb to Urotensin-II Receptor (human) (cytoplasmic loop) | 50 µg |
| ABR-OPA1-15348-C050 | PAb to G Protein-Coupled Receptor GPR97 (human) | 50 µg |
| ABR-OPA1-15349-C050 | PAb to G Protein-Coupled Receptor GPR97 (human) | 50 µg |
| ABR-OPA1-15350-C050 | PAb to G Protein-Coupled Receptor GPR97 (human) | 50 µg |
| ABR-OPA1-15351-C050 | PAb to Formyl Peptide Receptor-like 2 [FPRL2] (human) | 50 µg |
| ABR-OPA1-15352-C050 | PAb to Formyl Peptide Receptor-like 2 [FPRL2] (human) | 50 µg |
| ABR-OPA1-15353-C050 | PAb to Vasopressin V1B Receptor (human) | 50 µg |
| ABR-OPA1-15354-C050 | PAb to Vasopressin V1B Receptor (human) (cytoplasmic loop) | 50 µg |
| ABR-OPA1-15355-C050 | PAb to Urotensin-II Receptor (human) (NT) | 50 µg |
| ABR-OPA1-15356-C050 | PAb to P2Y12 Platelet ADP Receptor (human) (NT) (extracellular) | 50 µg |
| ABR-OPA1-15358-C050 | PAb to Lysophosphatidic Acid Receptor 4 (human) | 50 µg |
| ABR-OPA1-15359-C050 | PAb to Lysophosphatidic Acid Receptor 2 (human) | 50 µg |
| ABR-OPA1-15360-C050 | PAb to Histamine H4 Receptor (human) | 50 µg |
| ABR-OPA1-15361-C050 | PAb to G Protein-Coupled Receptor GPR25 (human) | 50 µg |
| ABR-OPA1-15363-C050 | PAb to Sphingolipid Receptor 5 (human) | 50 µg |
| ABR-OPA1-15364-C050 | PAb to Gastric Inhibitory Polypeptide Receptor (human) | 50 µg |
| ABR-OPA1-15365-C050 | PAb to Gastric Inhibitory Polypeptide Receptor (human) | 50 µg |
| ABR-OPA1-15366-C050 | PAb to CCR8 (human) | 50 µg |
| ABR-OPA1-15367-C050 | PAb to Complement Component 5a Receptor 1 (human) | 50 µg |
| ABR-OPA1-15370-C050 | PAb to Prostaglandin E Receptor EP4 (CT) | 50 µg |
| ABR-OPA1-15371-C050 | PAb to Prostaglandin E Receptor EP4 (human) | 50 µg |
| ABR-OPA1-15372-C050 | PAb to Prostaglandin E Receptor EP4 (human) | 50 µg |
| ABR-OPA1-15373-C050 | PAb to Olfactory Receptor OR2A4 (human) | 50 µg |
| ABR-OPA1-15374-C050 | PAb to Prolactin Releasing Hormone Receptor (human) | 50 µg |
| ABR-OPA1-15375-C050 | PAb to Dopamine Receptor D4 (human) (cytoplasmic loop) | 50 µg |
| ABR-OPA1-15376-C050 | PAb to G Protein-Coupled Receptor GPR18 (human) | 50 µg |
| ABR-OPA1-15379-C050 | PAb to Neuromedin U Receptor 1 (human) | 50 µg |
| ABR-OPA1-15380-C050 | PAb to G Protein-Coupled Receptor GPR35 (human) | 50 µg |
| ABR-OPA1-15381-C050 | PAb to alpha2c-Adrenergic Receptor (human) | 50 µg |
| ABR-OPA1-15382-C050 | PAb to Melanocortin 2 Receptor (human) | 50 µg |
| ABR-OPA1-15383-C050 | PAb to FSH Receptor (human) | 50 µg |
| ABR-OPA1-15384-C050 | PAb to G Protein-Coupled Receptor AGR9 (human) | 50 µg |
| ABR-OPA1-15385-C050 | PAb to Galanin Receptor GalR1 (human) | 50 µg |
| ABR-OPA1-15386-C050 | PAb to G Protein-Coupled Receptor AGR9 (human) | 50 µg |
| ABR-OPA1-15387-C050 | PAb to Tachykinin Receptor 3 (human) | 50 µg |
| ABR-OPA1-15388-C050 | PAb to Endothelin B Receptor-like P2 (human) | 50 µg |
| ABR-OPA1-15389-C050 | PAb to Endothelin B Receptor-like P2 (human) | 50 µg |
| ABR-OPA1-15390-C050 | PAb to Endothelin A Receptor (human) | 50 µg |
| ABR-OPA1-15391-C050 | PAb to Endothelin A Receptor (human) | 50 µg |
| ABR-OPA1-15392-C050 | PAb to G Protein-Coupled Receptor JEG18 (human) | 50 µg |
| ABR-OPA1-15394-C050 | PAb to Endothelin A Receptor (human) | 50 µg |
| ABR-OPA1-15395-C050 | PAb to G Protein-Coupled Receptor GPRC5C (human) | 50 µg |
| ABR-OPA1-15396-C050 | PAb to G Protein-Coupled Receptor GPRC5C (human) | 50 µg |
| ABR-OPA1-15398-C050 | PAb to G Protein-Coupled Receptor GPRC5B (human) | 50 µg |
| ABR-OPA1-15399-C050 | PAb to G Protein-Coupled Receptor JEG18 (human) | 50 µg |
| ABR-OPA1-15400-C050 | PAb to Galanin Receptor GalR1 (human) | 50 µg |
| ABR-OPA1-15401-C050 | PAb to G Protein-Coupled Receptor GPR26 (human) | 50 µg |
| ABR-OPA1-15402-C050 | PAb to G Protein-Coupled Receptor GPRC5B (human) | 50 µg |
| ABR-OPA1-15403-C050 | PAb to G Protein-Coupled Receptor LS195564 (human) | 50 µg |
| ABR-OPA1-15404-C050 | PAb to G Protein-Coupled Receptor GPRC5B (human) | 50 µg |
| ABR-OPA1-15405-C050 | PAb to Somatostatin Receptor Type 4 (human) | 50 µg |
| ABR-OPA1-15406-C050 | PAb to G Protein-Coupled Receptor GPCR-2037 (human) | 50 µg |
| ABR-OPA1-15407-C050 | PAb to Frizzled-1 (human) | 50 µg |
| ABR-OPA1-15408-C050 | PAb to Galanin Receptor GalR2 (human) | 50 µg |
| ABR-OPA1-15409-C050 | PAb to Galanin Receptor GalR2 (human) | 50 µg |
| ABR-OPA1-15410-C050 | PAb to Galanin Receptor GalR2 (human) | 50 µg |
| ABR-OPA1-15411-C050 | PAb to Melanocortin 4 Receptor (human) | 50 µg |
| ABR-OPA1-15412-C050 | PAb to G Protein-Coupled Receptor GPCR-2037 (human) | 50 µg |
| ABR-OPA1-15413-C050 | PAb to G Protein-Coupled Receptor GPCR-2037 (human) | 50 µg |
| ABR-OPA1-15414-C050 | PAb to beta3-Adrenergic Receptor (human) | 50 µg |
| ABR-OPA1-15415-C050 | PAb to beta3-Adrenergic Receptor (human) | 50 µg |
| ABR-OPA1-15416-C050 | PAb to beta3-Adrenergic Receptor (human) | 50 µg |
| ABR-OPA1-15417-C050 | PAb to Neuromedin U Receptor 2 (human) | 50 µg |
| ABR-OPA1-15418-C050 | PAb to G Protein-Coupled Receptor GPR17 (human) | 50 µg |
| ABR-OPA1-15419-C050 | PAb to G Protein-Coupled Receptor GPR17 (human) | 50 µg |
